keyword
https://read.qxmd.com/read/38515975/carl-jung-a-life-on-the-edge-of-reality-with-hypnagogia-hyperphantasia-and-hallucinations
#1
JOURNAL ARTICLE
Fatih Incekara, Jan Dirk Blom
Whether the Swiss psychiatrist Carl Jung (1875-1961) became psychotic after his mid-thirties is much debated. His recently published Black Books, a seven-volume journal, reveal new insights into this debate. Based on a phenomenological analysis of his self-reports in these books and in other writings, we here identify several types of anomalous perceptual experiences: hypnagogic-hypnopompic experiences, hyperphantasia, hallucinations, personifications, and sensed presence. We argue that these experiences were not indicative of a psychotic disorder, but rather stemmed from extremely vivid mental imagery, or hyperphantasia, a condition Jung's contemporaries and later biographers were unable to take into account because it had not yet been conceptualised...
2024: Frontiers in Psychology
https://read.qxmd.com/read/38426751/character-change-in-less-frequent-therapies-psychodynamic-and-transference-implications
#2
JOURNAL ARTICLE
Milton Viederman
An approach to a once-weekly, or bimonthly (every second week), ongoing psychodynamic psychotherapy is described. The detailed description of individual sessions is intended to show the process of the uncovering of unconscious phenomena using this approach, though the therapies described are not complete. Important changes that have already occurred are described. The approach is characterized by a direct method of discovery of early painful situations that underlie specific problematic experiences in the present...
March 2024: Psychodynamic Psychiatry
https://read.qxmd.com/read/38425327/a-dynamic-foundation-aberrations-of-sleep-architecture-and-its-association-with-clinical-and-sub-clinical-psychopathology
#3
REVIEW
Richard C Todd
This investigation centered on the hypnagogic and hypnopompic wake-sleep/sleep-wake transition states and the associated exploration of hypnagogic and hypnopompic experiences (HHEs), and sleep paralysis (SP) on psychiatric exacerbation and paradoxical masking. The study aims to discern causality by examining how these sleep-related experiences may contribute to the emergence or exacerbation of psychiatric and neurodegenerative conditions, particularly, pertaining to the clinical or sub-clinical demographic of Schizotypal Personality Disorder (STPD), Mood Disorders, Schizophrenia, Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder (GAD), Narcolepsy, Panic Disorder, specific phobias, or heightened psychotic sensitivity...
February 2024: Curēus
https://read.qxmd.com/read/38368061/sleep-related-hallucinations
#4
REVIEW
Flavie Waters, Ivan Ling, Somayyeh Azimi, Jan Dirk Blom
The diagnostic category of sleep-related hallucinations (SRH) replaces the previous category of Terrifying Hypnagogic Hallucinations in the 2001 edition of International Classification of Sleep Disorders-R. Hypnagogic and hypnopompic hallucinations (HHH) that occur in the absence of other symptoms or disorder and, within the limits of normal sleep, are most likely non-pathological. By contrast, complex nocturnal visual hallucinations (CNVH) may reflect a dimension of psychopathology reflecting different combinations of etiologic influences...
March 2024: Sleep Medicine Clinics
https://read.qxmd.com/read/38178978/to-be-or-not-to-be-hallucinating-implications-of-hypnagogic-hypnopompic-experiences-and-lucid-dreaming-for-brain-disorders
#5
JOURNAL ARTICLE
Guglielmo Foffani
The boundaries between waking and sleeping-when falling asleep (hypnagogic) or waking up (hypnopompic)-can be challenging for our ability to monitor and interpret reality. Without proper understanding, bizarre but relatively normal hypnagogic/hypnopompic experiences can be misinterpreted as psychotic hallucinations (occurring, by definition, in the fully awake state), potentially leading to stigma and misdiagnosis in clinical contexts and to misconception and bias in research contexts. This Perspective proposes that conceptual and practical understanding for differentiating hallucinations from hypnagogic/hypnopompic experiences may be offered by lucid dreaming, the state in which one is aware of dreaming while sleeping...
January 2024: PNAS Nexus
https://read.qxmd.com/read/38056083/quality-of-life-in-adolescents-with-narcolepsy-type-1-a-transversal-study-in-a-tertiary-hospital
#6
JOURNAL ARTICLE
Luís Salazar, Paula Manuel Vieira, Inês Cascais, Sónia Figueiroa, Marta Rios
PURPOSE: - Narcolepsy type 1 (NT1) is a rare chronic sleep disorder, usually arising by adolescence that negatively impacts quality of life. It is characterized by excessive daytime sleepiness (EDS), cataplexy, hypnagogic/hypnopompic hallucinations, sleep paralysis and sleep fragmentation. The goals of this work were to characterize NT1 adolescents regarding sleep characteristics, health-related quality of life (HRQoL) and future life perspectives and later to compare this group with a control group of healthy adolescents (HA)...
November 23, 2023: Sleep Medicine
https://read.qxmd.com/read/37851441/characteristics-of-recurrent-visions-of-the-nonphysical-world-among-cognitively-unimpaired-elders-of-the-ojibwe-tribal-nation
#7
JOURNAL ARTICLE
William G Mantyh, Adam D Block, Madelyn R Castro, Adam Hansen, Matti J Matheson, Corey Strong, Annamarie Hill, Zuzan Cayci, J Neil Henderson
IMPORTANCE: Visual hallucinations are a core feature of dementia with Lewy bodies and primary psychiatric disease, yet identification of a hallucination vs normal spiritual experience depends on cultural context. Almost no information exists in the medical literature regarding normal spiritual experiences in American Indian participants in the context of a neurocognitive evaluation. OBJECTIVE: To assess the characteristics of a normal spiritual experience in an Ojibwe Tribal Nation...
October 2, 2023: JAMA Network Open
https://read.qxmd.com/read/37477028/-sleep-paralysis-during-naptime-as-initial-symptom-of-narcolepsy
#8
P Villalobos-López, A Maldonado-Contreras
INTRODUCTION: Narcolepsy is a disease of unknown etiology, with a very low prevalence (0.02-0.16% in adults, although it must be higher, given the underdiagnosis), characterized by the presence of excessive daytime sleepiness, hypnagogic and/or hypnopompic hallucinations, sleep paralysis and/or cataplexy (if present, we speak of type 1 narcolepsy and, if not, type 2 narcolepsy), whose average diagnostic delay is between 10 and 15 years. CASE REPORT: A 16-year-old male who consulted after visiting different specialists for presenting sleep paralysis during naps, which cause him fear and occasional objects falling from his hands (diagnosed as possible myoclonus)...
July 28, 2023: Revista de Neurologia
https://read.qxmd.com/read/37181188/the-prevalence-of-sleep-paralysis-in-medical-students-in-buenos-aires-argentina
#9
JOURNAL ARTICLE
Juan Manuel Duarte, Gisela Roxana Lisi, Brendan T Carroll, Marcelo Fabián Garro, Francisco José Appiani
OBJECTIVES: The objectives of this study were to determine the prevalence of sleep paralysis (SP) in medical students from the University of Buenos Aires (UBA). MATERIALS AND METHODS: An ad hoc questionnaire based on the diagnosis of SP and a demographic survey was electronically presented to students of Internal Medicine at the School of Medicine of the UBA. The respondents answered both questionnaires using Google Forms® . RESULTS: The prevalence of SP was 40...
2023: Journal of Neurosciences in Rural Practice
https://read.qxmd.com/read/36108771/danavorexton-a-selective-orexin-2-receptor-agonist-provides-a-symptomatic-improvement-in-a-narcolepsy-mouse-model
#10
JOURNAL ARTICLE
Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Haruhide Kimura
Narcolepsy type 1 (NT1), caused by loss of orexin neurons, is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, disrupted nighttime sleep, hypnagogic/hypnopompic hallucinations and sleep paralysis, as well as a high risk of obesity. Danavorexton (TAK-925) is a novel brain-penetrant orexin 2 receptor (OX2R)-selective agonist currently being evaluated in clinical trials for the treatment of hypersomnia disorders including NT1. Thus, detailed characterization of danavorexton is critical for validating therapeutic potential of OX2R-selective agonists...
September 13, 2022: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/36043022/what-works-for-one-may-not-work-for-another-a-new-warning-for-modafinil
#11
Harim Kim, Girma M Ayele, Rediet T Atalay, Siham Hussien, Bereket Tewoldemedhin, Miriam B Michael, Steven M Scharf
Narcolepsy is a clinical syndrome of hypothalamic disorder characterized by several sleep-wake disorders. The most common features include daytime sleepiness associated with hallucinations (hypnagogic and hypnopompic hallucinations) at the transition time of sleep-wake time, cataplexy or sudden loss of muscle tone, and sleep paralysis. We present a case of a patient affected with both narcolepsy and postural orthostatic tachycardia syndrome (POTS). POTS is a rare disorder characterized by orthostatic intolerance and abnormal autonomic response while sustaining an upright posture...
July 2022: Curēus
https://read.qxmd.com/read/36017720/the-hypnagogic-state-a-brief-update
#12
REVIEW
Romain Ghibellini, Beat Meier
The hypnagogic state refers to a transitional stage between wakefulness and sleep, in which sensory perceptions can be experienced. In this review, we compile and discuss the recent scientific literature on hypnagogia research regarding the future directions proposed by Schacter (1976; Psychological Bulletin, 83, 452). After a short introduction discussing the terminology used in hypnagogia research and the differentiation of hypnagogic states with other related phenomena, we review the reported prevalence of hypnagogic states...
February 2023: Journal of Sleep Research
https://read.qxmd.com/read/35805480/characteristics-of-sleep-paralysis-and-its-association-with-anxiety-symptoms-perceived-stress-ptsd-and-other-variables-related-to-lifestyle-in-selected-high-stress-exposed-professions
#13
JOURNAL ARTICLE
Paulina Wróbel-Knybel, Michał Flis, Joanna Rog, Baland Jalal, Leszek Wołkowski, Hanna Karakuła-Juchnowicz
Sleep paralysis (SP) is a hypnagogic or hypnopompic state associated with the inability to move while conscious. Recurrent isolated sleep paralysis (RISP) is a type of REM parasomnia. Individuals experiencing anxiety disorders, PTSD, exposure to chronic stress, or shift work are at risk of developing this sleep disorder. This study aimed to assess: (1) the prevalence, frequency, and symptomatology of SP, and (2) the impact of the severity of anxiety symptoms, perceived stress, and lifestyle mode variables on the frequency and severity of SP in four professional groups at high risk of SP ( n = 844): nurses and midwives ( n = 172), policemen ( n = 174), teachers ( n = 107), and a group of mixed professions-"other professions" ( n = 391)...
June 25, 2022: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/35785587/prevalence-incidence-evolution-and-associated-factors-of-sleep-paralysis-in-a-longitudinal-study-of-the-us-general-population
#14
JOURNAL ARTICLE
M M Ohayon, A H Pakpour
BACKGROUND AND OBJECTIVE: Sleep paralysis is a common phenomenon which causes and consequences are seldomly studied. The aim of this study was to investigate the incidence and prevalence of sleep paralysis (SP) in the American adult population and its evolution on a 3-year period. METHODS: This longitudinal study was conducted between 2002 and 2015 and included a representative sample of the US general population. A total of 12,218 subjects were initially interviewed (W1) and 10,931 were re-interviewed three years later (W2)...
October 2022: Sleep Medicine
https://read.qxmd.com/read/35491942/lemborexant-an-orexin-receptor-antagonist-sedative-hypnotic-is-it-useful-for-insomnia-in-psychiatric-disorders
#15
REVIEW
Nicholas A Keks, Judy Hope
OBJECTIVE: Lemborexant, an orexin receptor antagonist similar to suvorexant, has been approved for the treatment of sleep onset and/or maintenance insomnia. Lemborexant is reviewed and compare to suvorexant from a psychiatric perspective. CONCLUSION: Rapidly absorbed (peak 1-3 h), lemborexant has a half-life of 17-19 h (suvorexant half-life 12 h). It is metabolized by CYP3A4/5, with no significant effects of age, sex or weight. Trials for insomnia indicate sustained efficacy beyond 6 months...
August 2022: Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists
https://read.qxmd.com/read/34458712/hypnopompic-hypersynchrony-a-hyper-read-hypno-pattern
#16
Neena Viswanathan, Sukriye Damla Kara, Kathleen Murray, Selim R Benbadis
No abstract text is available yet for this article.
2021: Epilepsy & behavior reports
https://read.qxmd.com/read/34262378/factors-associated-with-depression-and-sub-dimension-symptoms-in-adolescent-narcolepsy
#17
JOURNAL ARTICLE
Yang Yang, Chenyang Li, Long Zhao, Jing Li, Fang Han, Fulong Xiao
Objective: We evaluate the association between depression symptoms, clinical features (disease onset-age, disease duration, sleep-related hallucination), sleepiness, and polysomnography parameters in adolescent narcolepsy type 1 patients. Methods: Eighty-three adolescent narcolepsy type 1 patients were involved in this cross-sectional study. Patients completed questionnaires evaluating depression symptoms (Center for Epidemiologic Studies Depression Scale) and sleepiness (Epworth Sleepiness Scale)...
2021: Nature and Science of Sleep
https://read.qxmd.com/read/34158768/an-unusual-case-of-type-1-narcolepsy-in-an-ethiopian-patient
#18
Asefa Mekonnen, Gregory Stimac
BACKGROUND: Narcolepsy is a chronic disabling central neurological disorder of daytime hypersomnia. It is categorized into two subtypes-type 1 (N1) and type 2 (N2). Symptoms of N1 commonly include excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnogogic/hypnopompic hallucinations, and disturbed nighttime sleep. Ethnic differences have been observed, but they have not been reported in an Ethiopian patient to date. CASE DETAIL: We report a 39-year-old Ethiopian patient with type 1 narcolepsy whose diagnosis was delayed for three decades despite severe symptoms...
January 2021: Ethiopian Journal of Health Sciences
https://read.qxmd.com/read/34062377/in-the-twilight-zone-an-epidemiological-study-of-sleep-related-hallucinations
#19
JOURNAL ARTICLE
Josef J Bless, Kenneth Hugdahl, Bodil Kråkvik, Einar Vedul-Kjelsås, Anne Martha Kalhovde, Janne Grønli, Frank Larøi
BACKGROUND: Few studies have investigated hallucinations that occur at the onset/offset of sleep (called hypnagogic/hypnopompic hallucinations; HHHs), despite the fact that their prevalence in the general population is reported to be higher than the prevalence of daytime hallucinations. We utilized data from an epidemiological study to explore the prevalence of HHHs in various modalities. We also investigated phenomenological differences between sleep-related (HHHs) and daytime hallucinations in the auditory modality...
July 2021: Comprehensive Psychiatry
https://read.qxmd.com/read/33913284/-study-on-the-prediction-of-cardiovascular-disease-based-on-sleep-heart-rate-variability-analysis
#20
JOURNAL ARTICLE
Ye Yang, Xueya Yan, Fengzhen Hou, Lei Pan
The peak period of cardiovascular disease (CVD) is around the time of awakening in the morning, which may be related to the surge of sympathetic activity at the end of nocturnal sleep. This paper chose 140 participants as study object, 70 of which had occurred CVD events while the rest hadn't during a two-year follow-up period. A two-layer model was proposed to investigate whether hypnopompic heart rate variability (HRV) was informative to distinguish these two types of participants. In the proposed model, the extreme gradient boosting algorithm (XGBoost) was used to construct a classifier in the first layer...
April 25, 2021: Sheng Wu Yi Xue Gong Cheng Xue za Zhi, Journal of Biomedical Engineering, Shengwu Yixue Gongchengxue Zazhi
keyword
keyword
166161
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.